NCT05390918 · Jeff Bridge
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
(TAILOR)
What this study is about
This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.
View original scientific description
This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Nationwide Children's Hospital patients
- Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent
- Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days)
- Resides with primary caregiver who has legal authority to consent to research participation
Exclusion criteria
- Suicide attempt in the past 3 months
- Diagnosis of Bipolar Disorder or Psychosis
- Having a change to an antipsychotic and/or mood stabilizer medication regimen within the last 2 months
- Snoring at least 3 nights per week that can be heard a room or two away, even without a cold or flu or during allergy season
- Gasping for air while sleeping, diagnosis of Obstructive Sleep Apnea, or turning blue within the past year
- Body Mass Index \> 40
- Daytime symptoms of Restless Leg Syndrome
- Diagnosis of Narcolepsy
- Diagnosis of Seizures or Epilepsy, or prescribed anticonvulsant medication, within the past 4 years
- Significant substance use in the past month
- Currently receiving sleep disorder services from a sleep clinic
- Inability to speak/read English adequately to understand and complete study consent and procedures
- No access to a telephone or internet-connecting device
- Sibling already in the study
Where
- Columbus, Ohio
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Feb 5, 2026 · Source of record for eligibility and locations